Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease

Authors

Lawrence W. Elmer, Department of Neurology, University of Toledo College of Medicine, 3120 Glendale Avenue, Toledo, OH, 43614, USA. Lawrence.Elmer@utoledo.edu.
Jorge L. Juncos, Department of Neurology and Movement Disorders, Emory University School of Medicine, Atlanta, GA, USA.
Carlos Singer, Department of Neurology, University of Miami, Miami, FL, USA.
Daniel D. Truong, The Parkinson's and Movement Disorder Institute, Fountain Valley, CA, USA.
Susan R. Criswell, Department of Neurology, Washington University, St. Louis, MO, USA.
Sotirios Parashos, Struthers Parkinson's Center, Golden Valley, MN, USA.
Larissa Felt, Adamas Pharmaceuticals, Inc., Emeryville, CA, USA.
Reed Johnson, Adamas Pharmaceuticals, Inc., Emeryville, CA, USA.
Rajiv Patni, Adamas Pharmaceuticals, Inc., Emeryville, CA, USA.

Document Type

Article

Abstract

An Online First version of this article was made available online at http://link.springer.com/journal/40263/onlineFirst/page/1 on 12 March 2018. An error was subsequently identified in the article, and the following correction should be noted.

Publication Date

4-1-2018

Publication Title

CNS drugs

E-ISSN

1179-1934

Volume

32

Issue

4

First Page

399

Last Page

400

PubMed ID

29637528

Digital Object Identifier (DOI)

10.1007/s40263-018-0510-z

Recommended Citation

Elmer, Lawrence W.; Juncos, Jorge L.; Singer, Carlos; Truong, Daniel D.; Criswell, Susan R.; Parashos, Sotirios; Felt, Larissa; Johnson, Reed; and Patni, Rajiv, "Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease" (2018). Neurology. 1252.
https://scholar.barrowneuro.org/neurology/1252